Three Sixty North Masks the Mumbai Margin Squeeze
A landmark ₹8,000 crore NCR debut distracts from Q1's sequential revenue collapse and residential margin compression. Management's upgraded ₹100–120 billion sales guidance looks premature while Phase 2 timing remains undefined.
The real story: Q1 is a sequential cliff
Headline numbers look strong—revenue up 31.7% year-on-year, profit up 29%—but the quarter tells a different story on the sequential tape. Residential revenue collapsed to ₹880 crore, down 37% quarter-on-quarter from the ₹1,300–1,400 crore range of the prior three quarters. Operating margin compressed 300 basis points: residential now 51–52% versus 55% historical. Management attributes the miss to payment and possession timing ('if somebody pays on 5 July instead of 30 June, recognition gets deferred'), but the scale of the miss—and the margin squeeze—suggests execution pressure running deeper than timing alone.
₹880 Cr
vs. ₹1,350 Cr avg prior 3Q
–37%
YoY revenue still +31.7%
51–52%
vs. 55% prior; –300 bps
56.4%
Stable YoY; NPM 39.9%
What holds up: the NCR validation
Three Sixty North Phase 1 is real. ₹8,000 crore in gross bookings, with 1.4 million square feet sold (of a 2.6M sq ft total project), allotments complete, and financial closure locked in. This is no small win; it is the first time a Mumbai-listed developer has cracked the NCR residential market at scale with a single project. Management claims it proves they have 'cracked the code' on volume and quality execution. The claim is half-true: the single project proof-point exists. But the broader claim—that Oberoi can sustain ₹100–120 billion in annual sales (up from a ₹60–70 billion prior assumption) while keeping margins above 50%—has not yet been tested at portfolio scale, especially with Phase 2 timing still undefined and Mumbai approvals on a tight schedule.
We have cracked the code on volumes and quality execution
ContradictedResidential revenue ₹880 Cr down from ₹1,300–1,400 Cr prior quarters (–37% QoQ). Residential OPM 51–52% vs. 55% historical.
Sustain ₹100–120B annual sales at 50%+ margins
OverstatedQ1 delivered ₹1,301 Cr (~₹52B annualized), down 25.7% QoQ. Margin compressed 300 bps. No proof at scale.
Three Sixty North Phase 1 sold entirely; financial closure complete
Supported₹8,000 Cr gross bookings confirmed; 1.4M sq ft sold; allotments done. Distanced from court ruling.
Annuity portfolio near 100% occupancy; Sky City 82% in Year 1
SupportedCommerz I/II/III + Oberoi Mall reported near 100%. Sky City 82% occupancy, managing to steady state.
No cost inflation impact; margin moves are purely project mix
PartialProject margins range 43–65%. Q1 residential miss suggests underlying pressure beyond mix.
What changed: NCR upgrades the playbook, but FY27 execution is hedged
Prior calls gave no explicit guidance. This time, management quantified a major upgrade: ₹100–120 billion in annual sales for FY27–28 (versus a ₹60–70 billion prior assumption). This is driven by Three Sixty North Phase 2 (1.2M sq ft remaining; launch timing 'not yet decided'), plus a flurry of Mumbai launches—Adarsh Nagar (Q3 FY27, IOD pending), Aurelius (Pedder Road), Thane towers (two projects), Alibaug, and Tardeo. When pressed on Phase 2 launch timing and strategy, management deferred: 'how we'll launch, when we'll launch, and at what price we'll launch, we still want to discuss that internally.' This is as close to admitting internal disagreement as you get on an earnings call. The narrative has shifted from 'project-by-project delivery' to 'we've cracked portfolio-scale execution' (18 towers of 60–65 floors cited as proof), but the proof is not yet visible in the numbers.
The margin squeeze: explained but not resolved
Management blames the residential margin compression (51–52% vs. 55%) on 'project mix'—Three Sixty North and other ongoing projects span a 43–65% margin range depending on stage, location, and product segment. This is plausible in theory. But in practice, the scale of the Q1 margin miss, paired with the revenue miss, suggests pricing or cost pressure that a pure mix argument doesn't fully address. Management argues margins have 'nothing to do with how much you sell'—a claim that sounds defensive when the call backdrop is a year-over-year margin decline despite positive pricing in secondary markets (Borivali, Goregaon). If cost inflation or competitive pressure forces Oberoi to defend market share at lower realized pricing, the ₹100–120 billion guidance at 50%+ margins becomes a stretch. This is the single largest risk to the bull case.
The street's verdict: skepticism has set in
The market's initial reaction was muted and has deteriorated. On day 1 after the result announcement (17 July), the stock fell 0.64%. By day 3 it was down 2.29%, and by day 5 it had slipped to –3.88%. The initial pop never materialized; instead, the story faded. Today's price of ₹1,858 sits 6.45% below its all-time high but remains 33.55% above the 52-week low, trading above its 20-, 50-, and 200-day moving averages. However, the technical picture is deteriorating: RSI stands at a neutral 52.4, and increasing volume is not yet confirming a sustained rally.
Institutional flows tell the real story. Foreign institutional investors (FII) have been steadily trimming. FII ownership peaked at 19.97% a year ago; by Q1 FY27 it had fallen to 15.11% (a loss of 486 basis points year-on-year). This quarter alone FII dropped 31 basis points, while domestic institutional investors added a modest 25 basis points. FII outflows of this magnitude, while the company is pitching a multi-year ₹100–120 billion upside, signal that global money is not yet convinced by the execution narrative. The stock's price action and ownership flows align: wait-and-see skepticism, not conviction.
Risks, ranked by how much they should concern a holder
Three Sixty North Phase 1 (₹8,000 Cr bookings) validates NCR strategy and proves scale execution
Upgraded FY27–28 annual sales guidance to ₹100–120 billion (from ₹60–70B) is material upside
Annuity portfolio (Commerz, Oberoi Mall, Sky City) is stable and ramping; provides cash buffer
Brand moat with customer-led secondary price appreciation; luxury segment absorbing price increases
18 concurrent towers under construction (60–65 floors) shows portfolio-scale execution ambition
Q1 residential revenue collapsed 37% QoQ (₹880 Cr vs. ₹1,300–1,400 Cr prior)—execution credibility hit
Residential margin compression 51–52% vs. 55% (–300 bps) unaddressed; threatens 50%+ guidance at scale
Three Sixty North Phase 2 (1.2M sq ft, 46% of total) launch timing and pricing strategy still 'not decided'
Multiple FY27 launches (Adarsh Nagar Q3, others) on tight timeline; approval risk (IOD pending) and execution pressure real
FII outflows accelerating: down 486 bps year-on-year (19.97% → 15.11%); institutions losing conviction
Three Sixty West off-take slowing (4 units Q2 FY26 → 1 unit Q1 FY27); inventory liquidation dependent on new launches
Litigation on Three Sixty North dismissed as 'no refund requests' but real exposure if pricing/delivery falters
Execution at scale unproven; Phase 2 launch timing undefined
MediumPhase 2 (1.2M sq ft, 46% of project) is central to ₹100–120B guidance. 'Not decided' means internal disagreement; delays would signal broader execution risk. Adarsh Nagar (Q3 FY27) is the near-term test; IOD still pending.
Margin compression not addressed; threatens 50%+ guidance
MediumResidential margin fell 51–52% vs. 55% despite strong ₹8,000 Cr Three Sixty North bookings. If inflation/competition persists, 50%+ at ₹100–120B scale is unachievable. No mitigation articulated beyond 'project mix.'
Revenue recognition timing volatility creates quarterly swings
Low–MediumQ1 ₹880 Cr residential (vs. ₹1,300–1,400 Cr prior 3Q) blamed on payment/possession delays. Order book said intact, but sequential miss could signal demand softness if not reversed in Q2.
Litigation risk on Three Sixty North downplayed
MediumCourt case emerged; management claims no refund requests and customers 'waiting.' Optimistic framing with no disclosure of substance or exposure. Real risk if delivery or pricing falters.
FY27 launch pipeline execution pressure
MediumFive named projects (Adarsh Nagar, Aurelius, Thane, Alibaug, Tardeo) plus Ritz-Carlton handover, all targeting FY27. Approval delays or supply-chain issues would push launches to FY28, materially impacting guidance.
1 · Q2 residential revenue rebound
If ₹1,300+ crore residential revenue doesn't return, the Q1 miss was not timing but a signal of demand softness or order book depletion. This is THE number to watch. A rebound validates the 'order book intact' claim; continued softness means the 'cracked code' narrative is unproven.
2 · Adarsh Nagar launch timeline (Q3 FY27 target)
IOD (Intimation of Ownership) still pending. A Q3 launch on-time would prove FY27 execution credibility. A slip to Q4 or FY28 would signal broader approval risk and cast doubt on the broader FY27 pipeline (Aurelius, Thane, etc.).
3 · Three Sixty North Phase 2 strategy reset
Management must clarify: staggered launch (lower execution risk) or one-go (higher velocity but higher risk)? Pricing strategy? Timing relative to Phase 1 cash generation? Continued vagueness ('not decided') suggests internal disagreement and would be a red flag.
The debate
The single number to track from here
Q2 FY27 residential revenue. If it recovers to ₹1,300+ crore, the Q1 miss was timing, and the order-book claim holds. If it stays depressed (₹1,000 Cr or below), there is a demand or deferred-recognition problem hiding under management's 'cracked code' rhetoric. This is where credibility either returns or erodes.
Oberoi Realty is a high-quality franchise attempting a step-change—from a pure Mumbai luxury player to a national developer with NCR scale ambition. Three Sixty North Phase 1 is real and proves the model works at one project. But one project does not a portfolio make. The sequential miss in residential revenue and the unexplained margin compression are red flags masking under the headline gains. FII outflows confirm the street is skeptical. Management's claims of execution prowess will be tested hard over the next two quarters. The verdict today is Hold—not a sell, but not a buy until execution is proven at portfolio scale. Watch Q2 residential revenue and Adarsh Nagar timing closely. That's where credibility is either earned or lost.
Informational and educational content only. Not investment advice.